Gyroscope secures $148M to develop treatment for rare eye diseases
Longevity Technology - 29-Mar-2021Funds to advance gene therapy for age-related macular degeneration & innovative delivery system
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
General partner at Forbion and Board member at Gyroscope Therapeutics
Visit website: https://forbion.com/en/team/wouter_joustra
See also
London-based company developing gene therapies and delivery technologies for eye diseases
Details last updated 31-Mar-2021
Funds to advance gene therapy for age-related macular degeneration & innovative delivery system